Search
Now showing items 1-1 of 1
Diverse Approaches to Developing Combination Therapies for NF1-Mutant Cancers
(2015-05-13)
The NF1 tumor suppressor is lost or mutated in a variety of sporadic cancers, as well as in the hereditary cancer predisposition syndrome neurofibromatosis type 1 (NF1). NF1 patients have an 8–13% risk of developing a ...